Patents Assigned to Abbott Diabetes Care Inc.
  • Patent number: 11911151
    Abstract: An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte.
    Type: Grant
    Filed: October 6, 2022
    Date of Patent: February 27, 2024
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Thomas A. Peyser, Adam Heller
  • Patent number: 11896371
    Abstract: Methods, devices, and systems are provided for correcting lag in measurements of analyte concentration level in interstitial fluid. The invention includes receiving a signal representative of sensor data from an analyte monitoring system related to an analyte level measured over time, computing rates of change of the sensor data for a time period of the sensor data, computing a rate distribution of the rates of change, transforming the rate distribution into a linear arrangement, determining a best-fit line for the transformed rate distribution, computing a slope of the best-fit line; and using the slope of the best-fit line as a representation of a variability of the analyte level to adjust an amount of lag correction applied to the sensor data. Numerous additional features are disclosed.
    Type: Grant
    Filed: October 19, 2020
    Date of Patent: February 13, 2024
    Assignee: ABBOTT DIABETES CARE INC.
    Inventor: Erwin Satrya Budiman
  • Publication number: 20240033429
    Abstract: Method and system for providing an integrated analyte monitoring system and on-body patch pump with multiple cannulas and a sensor combination is provided.
    Type: Application
    Filed: October 6, 2023
    Publication date: February 1, 2024
    Applicant: Abbott Diabetes Care Inc.
    Inventor: R. Curtis JENNEWINE
  • Publication number: 20240040348
    Abstract: Embodiments described herein include a data receiving device for an analyte monitoring system. The data receiving device detects a disconnect between the data receiving device and a sensor control device of the analyte monitoring system. The data receiving device sets a duration of a scan window for receiving connection data packets from the sensor control device to a current length and initiates the scan window. In response to determining that a connection between the data receiving device and sensor control device has not been established based on connection data packets received during the scan window, the data receiving device performs iterations of a process to adjust the scan window, involving increasing a duration of the scan window to a new length that is greater than the current length and initiating the scan window based on the duration of the scan window at the new length.
    Type: Application
    Filed: July 18, 2023
    Publication date: February 1, 2024
    Applicant: ABBOTT DIABETES CARE INC.
    Inventors: Xuandong Hua, Danny Chan
  • Publication number: 20240027390
    Abstract: Analyte sensor comprises a substrate having an upper surface including a first portion and a second exposed portion, an electrode layer disposed on the first portion and having an elongate body comprising a proximal end and a distal end, the electrode layer including an active working electrode area having a surface area of between 0.15 mm2 to 0.25 mm2, at least one sensing spot with at least one analyte responsive enzyme disposed on the active working electrode area. Additional analyte sensors are disclosed.
    Type: Application
    Filed: July 18, 2023
    Publication date: January 25, 2024
    Applicant: ABBOTT DIABETES CARE INC.
    Inventors: Udo Hoss, Max Garbett, Andrew James Bull, Stephen Oja, Benjamin J. Feldman, Lam N. Tran, Jean-Pierre Babka, Mark Stephen Yahnke, Tahir S. Khan, Adrian Petyt, Mark Alan Schulz, Andrew McGibbon, Owen Daniel Reynolds
  • Patent number: 11872370
    Abstract: A medical device includes an antenna external to a case, package, or encapsulant for the electronic systems of the medical device. In one embodiment, a diabetes infusion pump is enclosed within a metal case, the pump including a processor and a communication module for wireless communications. An antenna is disposed in the delivery tubing of the pump outside the case with an antenna feed interconnecting the external antenna with the internal communication module. In another aspect, a thin film antenna is formed on the outer surface of the case in which a physiological parameter sensor, such as a glucose sensor, is enclosed. Multiple antennas may be used for communications on different frequencies.
    Type: Grant
    Filed: February 14, 2023
    Date of Patent: January 16, 2024
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Nathan C. Crouther, Marc B. Taub, Lei He
  • Patent number: 11872039
    Abstract: Method and system for providing continuous calibration of analyte sensors includes calibrating a first sensor, receiving data associated with detected analyte levels from the first sensor, and calibrating a second sensor based on a predetermined scaling factor and data associated with detected analyte levels from the first sensor, is disclosed.
    Type: Grant
    Filed: November 5, 2018
    Date of Patent: January 16, 2024
    Assignee: ABBOTT DIABETES CARE INC.
    Inventor: Benjamin Jay Feldman
  • Publication number: 20240008769
    Abstract: An analyte monitoring system with a sensor control device including an electronics housing. The housing can include a shell disposed opposite a mount, each including an aperture which is axially aligned with the other aperture. The inner surfaces are aligned, and a seal is disposed within the interior space. The housing also includes a circuit board disposed within the interior space of the housing, and an analyte sensor having a proximal portion and a distal portion, the proximal portion coupled with the circuit board, and the distal portion configured to measure a glucose level in a bodily fluid and extending from a bottom of the electronics housing.
    Type: Application
    Filed: July 11, 2023
    Publication date: January 11, 2024
    Applicant: ABBOTT DIABETES CARE INC.
    Inventors: Matthew Simmons, Steven Mitchell, Vivek Rao, Namvar Kiaie
  • Patent number: 11864894
    Abstract: Method and apparatus for providing calibration of analyte sensor including applying a control signal, detecting a measured response to the control signal, determining a variance in the detected measured response, and estimating a sensor sensitivity based on the variance in the detected measured response is provided.
    Type: Grant
    Filed: March 21, 2022
    Date of Patent: January 9, 2024
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Gary Alan Hayter, Kenneth J. Doniger, Erwin Satrya Budiman, Songbiao Zhang, John Charles Mazza
  • Patent number: 11867652
    Abstract: An analyte sensor comprising: a non-conductive material; a conductive material disposed on the non-conductive material; and at least two sensing structures defined by a removed portion of the conductive material, the at least two sensing structures comprising a reagent composition.
    Type: Grant
    Filed: February 28, 2022
    Date of Patent: January 9, 2024
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Udo Hoss, Tahir Sadik Khan, Phu X. Le
  • Publication number: 20240000348
    Abstract: A medical system comprising: an analyte sensor for receiving an analyte signal corresponding to an analyte concentration of a user; a health monitor device comprising a display unit and in communication with the analyte sensor, the health monitor device comprising a processor and memory communicably coupled to the processor, the memory including instructions stored therein that, when executed by the processor, cause the processor to: receive the analyte signal from the analyte sensor; determine the analyte concentration based on the analyte signal; calculate a recommended medication dosage based on the analyte concentration; associate a current parameter type with the recommended medication dosage; associate the current parameter type to at least one corresponding stored historical parameter type associated with a historical medication dosage; and display, on the display unit, the recommended medication dosage and the historical medication dosage.
    Type: Application
    Filed: September 18, 2023
    Publication date: January 4, 2024
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Marc B. TAUB, Nathan C. CROUTHER, Jai KARAN
  • Publication number: 20230414137
    Abstract: Methods and apparatus for providing data processing and control for use in a medical communication system are provided.
    Type: Application
    Filed: September 13, 2023
    Publication date: December 28, 2023
    Applicant: ABBOTT DIABETES CARE INC.
    Inventor: Gary Alan Hayter
  • Patent number: 11854693
    Abstract: The present disclosure includes methods, devices and systems for establishing a connection between a medical device and a remote computing device, receiving an upgrade command at the medical device, storing a current version of persistent data and a current version of executable code in a first storage area of the medical device, transmitting at least the current version of the persistent data to the remote computing device, receiving a second format of the current version of the persistent data and an upgraded version of executable code at the medical device, storing the second format of the current version of the persistent data and the upgraded version of the executable code in a second storage area of the medical device, and executing the upgraded version of the executable code with the second format of the current version of the persistent data.
    Type: Grant
    Filed: November 21, 2022
    Date of Patent: December 26, 2023
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Saeed Nekoomaram, Nathan C. Crouther
  • Publication number: 20230404449
    Abstract: Methods and devices to detect analyte in body fluid are provided. Embodiments include positioning an analyte sensor in fluid contact with an analyte, detecting an attenuation in a signal from an analyte sensor after positioning during a predetermined time period, receiving the data corresponding to an analyte level, providing a notification on the user interface that comprises a request for a blood analyte measurement, receiving an indication, based on the blood analyte measurement, of an absence of the error condition, and in response to receiving the indication, configuring the user interface to report the data corresponding to the analyte level, where the user interface was previously configured to not report the data corresponding to the analyte level.
    Type: Application
    Filed: August 30, 2023
    Publication date: December 21, 2023
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Wesley Scott Harper, Timothy Christian Dunn, Erwin Satrya Budiman, Kenneth J. Doniger, Gary Alan Hayter
  • Publication number: 20230397849
    Abstract: Low profile continuous analyte measurement systems and systems and methods for implantation within the skin of a patient are provided.
    Type: Application
    Filed: August 23, 2023
    Publication date: December 14, 2023
    Applicant: ABBOTT DIABETES CARE INC.
    Inventors: Udo Hoss, John Charles Mazza, Phu Le
  • Publication number: 20230389830
    Abstract: Low profile continuous analyte measurement systems and systems and methods for implantation within the skin of a patient are provided.
    Type: Application
    Filed: August 23, 2023
    Publication date: December 7, 2023
    Applicant: ABBOTT DIABETES CARE INC.
    Inventors: Udo Hoss, John Charles Mazza, Phu Le
  • Publication number: 20230389831
    Abstract: Low profile continuous analyte measurement systems and systems and methods for implantation within the skin of a patient are provided.
    Type: Application
    Filed: August 23, 2023
    Publication date: December 7, 2023
    Applicant: ABBOTT DIABETES CARE INC.
    Inventors: Udo Hoss, John Charles Mazza, Phu Le
  • Publication number: 20230389838
    Abstract: Systems, devices, kits, and methods are provided herein in the form of example embodiments that relate to calibration of medical devices. The medical devices can be sensors adapted to sense a biochemical attribute. The embodiments can be used to determine calibration information specific to an individual medical device. The embodiments can determine the calibration information by reference to one or more parameters obtained during manufacturing of the medical device. The embodiments can also determine the calibration information by reference to in vitro testing of the medical devices. The embodiments also apply to systems incorporating those medical devices in their use in the field. Also described are embodiments of modifications to surfaces of sensor substrates, such as through applied radiation and/or the creation of a well, to aid in the placement and/or sizing of a sensor element on the substrate.
    Type: Application
    Filed: August 15, 2023
    Publication date: December 7, 2023
    Applicant: ABBOTT DIABETES CARE INC.
    Inventors: Steven Scott, Christopher J. Bennell, Claire Bhogal, Katie A. Cranfield, Marc B. Taub, Bree M. Winter, Owen D. Reynolds, Jean-Pierre Babka, Dharmendra S. Patel, Christopher A. Thomas, Udo Hoss, Mark S. Yahnke, Tahir S. Khan
  • Patent number: D1010133
    Type: Grant
    Filed: March 22, 2019
    Date of Patent: January 2, 2024
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Philip Yee, Samuel Mason Curry
  • Patent number: D1015366
    Type: Grant
    Filed: July 12, 2022
    Date of Patent: February 20, 2024
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Gary A. Hayter, Timothy C. Dunn, Yashesvini V. Ram, Claire A. Cunningham, Justin N. Williams, William Koo Lee